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Mitral valve repair surgery for mitral regurgitation (MR)
has a multi-decade history beginning in the 1950s with
Davila and colleagues’1 circumferential suture mitral annu-
loplasty and Lillehei and colleagues’2 suture commissural
fusion. In 1960, McGoon3 pioneered direct leaflet repair
via interrupted suture plication of the prolapsed leaflet seg-
ment. By the next decade, Carpentier and colleagues4 had
developed a host of novel reconstructive techniques ranging
from leaflet resection to native chordal repositioning, all
augmented by remodeling prosthetic ring annuloplasty. De-
cades later, the classic quadrangular resection remains for
most surgeons, the mitral valve repair technique of choice.
The capability for high-probability mitral repair success
now justifies early operation in asymptomatic patients.5
The opportunity for patients to undergo minimally invasive
operations and percutaneous transcatheter repair has onlyfurther magnified the drive toward earlier surgery and the
need for near 100% valve repair success.6-9
Despite the overwhelming success of quadrangular re-
section, minor drawbacks persist relating to irreversibility
of leaflet resection, time-consuming leaflet reapproxima-
tion with sliding annuloplasty, monoleaflet function, and
systolic anterior motion (SAM) risk. Neochord construction
mitigates many of these but has the challenge of precise siz-
ing and possibility of leaving excessive tissue, risking SAM.
In seeking a mitral repair technique that avoids the potential
negatives of leaflet resection and neochords, while also fa-
cilitating minimally invasive operations by reducing leaflet
manipulation and simplifying suture management, we used
a slight modification of the McGoon3 plication repair in 87
patients. Single suture imbrication of excess prolapsed tis-
sue onto the noncoaptation ventricular side of the leaflet ef-
ficiently remodeled the leaflet into a smooth nonprolapsed
coapting surface.
OPERATIVE TECHNIQUE
A minimally invasive approach was used in the majority
of patients and has been described by Woo.6 In these pa-
tients and patients undergoing sternotomy, mitral ring annu-
loplasty sutures were placed immediately after atriotomy
and retracted under slight tension to optimize exposure
and inspection of leaflet pathology (Figure 1, A). As origi-
nally3 and subsequently10 described, theMcGoon repair en-
tailed an interrupted suture placed through the leaflet
margin at one end of the prolapsed segment and brought
out through the other end. Additional sutures were placed
in parallel toward the annulus with progressively widening
amount of leaflet tissue sutured. Tying the sutures pleated
the leaflet, generating ‘‘slight bulkiness of the plicated por-
tion’’10 and eliminating the prolapse.rdiovascular Surgery c Volume 143, Number 3 749
FIGURE 1. Endoscopic view of mitral valve during minimally invasive approach. Mitral ring annuloplasty sutures are placed and retracted under tension
before leaflet inspection to facilitate exposure and examination of the mitral valve. A, Large flail P2 segment is shown. A standard quadrangular resection
would entail removal of this entire region. B, Instead of resecting the large P2 segment, a tiny portion of the leaflet tissue leading edge, right at the ruptured
chord, is inverted into the left ventricle and secured with a CV5 polytetrafluoroethylene (Gore-Tex; WLGore & Associates Inc, Flagstaff, Ariz) suture. This
suture is then double-run posteriorly for a short distance toward the annulus. C, Without the aid of the annuloplasty ring, the mitral valve with its remodeled
leaflet is pressure tested and found to be completely competent. The posterior leaflet contributes to the overall mitral valve function and total mitral orifice
area. D, Sizing the annuloplasty ring to the entire mitral valve orifice area.
Surgical TechniquesOur technique differs slightly, in that the leading edge of
the prolapsed segment was grasped and inverted into the left
ventricle, imbricating a small portion of leaflet tissue and
presenting 2 short, near-apposing lines of tissue easily
approximated with a double-running CV5 polytetrafluoro-
ethylene (Gore-Tex; WL Gore & Associates Inc, Flagstaff,
Ariz) suture, which then fixates the inverted leaflet tissue
(Figure 1, B). The width of inverted segment is narrowed in-
stead of widened as the annulus is approached. With the ex-
cess leaflet tissue transposed to the ventricular side of the
leaflet, a smooth coaptation surface remains.
Saline pressure testing at this time usually demonstrates
elimination of MR. The repaired mitral leaflet will usually750 The Journal of Thoracic and Cardiovascular Surgappear fully restored, resembling a normal leaflet
(Figure 1, C). Nevertheless, a ring annuloplasty was always
performed to reshape the annulus, reduce demands on the
leaflets, and prevent future annular dilatation. A complete
ring was sized to the entire mitral valve orifice area
(Figure 1, D). A composite intraoperative video of a mini-
mally invasive P2 prolapse repair including pre- and post-
bypass transesophageal echocardiography (TEE) is
provided (Video 1).
RESULTS
This study received University of Pennsylvania Institu-
tional Review Board approval (810968). Between Mayery c March 2012
TABLE 1. Patient data
No. of patients 87
Gender 59 male (68%)
Age, mean 61.2  14.4 y
(range, 22–89)
Ejection fraction, mean 58%  10%
(range, 15–80)
NYHA functional class, median 2
Hypertension 50 (57%)
Smoking 41 (47%)
Diabetes 10 (11%)
Previous cardiac operation 2 (2%)
Minimally invasive approach 54 patients (62%)
Minimally invasive approach converted to
sternotomy
0 patients
Concomitant procedures 36 procedures in
28 patients (32%)
Cardiopulmonary bypass time, mean 127  59 min
Crossclamp time, mean 85  41 min
Posterior leaflet prolapse/flail 74 (85%)
Anterior/Barlow’s bileaflet disease 13 (15%)
Prerepair MR grade, mean (0–4 scale) 3.7  0.4
Postrepair MR grade, mean 0.1  0.3
Length of stay, median 7 d (range, 4–21)
Ring size, mean 31.4  3.1 mm
(range, 26–40)
Ring type:
Carpentier-Edwards Physio (Edwards
Lifesciences, LLC, Irvine, Calif)
39 (45%)
Carpentier-Edwards Physio II (Edwards
Lifesciences, LLC)
18 (21%)
Medtronic Profile 3D (Medtronic, Inc,
Minneapolis, Minn)
22 (25%)
St Jude Seguin (St Jude Medical Inc,
St Paul, Minn)
3 (4%)
Medtronic Colvin-Galloway Future Band
(Medtronic, Inc)
3 (4%)
Medtronic Duran (Medtronic, Inc) 1 (1%)
Sorin Memo 3D (Sorin Group,
Milan, Italy)
1 (1%)
Perioperative complications
Death 0
Stroke 0
Myocardial infarction 0
Reexploration 0
NYHA, New York Heart Association; MR, mitral regurgitation.
Surgical Techniques2007 and May 2011, 87 patients with degenerative mitral
valve regurgitation underwent leaflet remodeling mitral re-
pair. Perioperative data are summarized in Table 1. Repair
success rate was 100%. No patients underwent mitral valve
replacement. All repairs were successful on the first attempt.
No patient required recrossclamp for repair adjustment.
Eighty-one of 87 patients had zero MR on postbypass TEE
and 6 of 87 patients had 1þMR. No patients had SAM.
Two patients required intra-aortic balloon pumps
(IABPs) for postcardiopulmonary bypass left ventricularThe Journal of Thoracic and Cadysfunction. The first patient had a preoperative left ven-
tricular ejection fraction of 15% and underwent mitral
plus tricuspid valve repair. His IABP was removed after
40 hours, and he was discharged on postoperative day
12. The second patient had a preoperative left ventricular
ejection fraction of 35% and received mitral repair, aortic
valve replacement, and tricuspid repair. She underwent
IABP removal after 17 hours and was discharged on post-
operative day 13.
Clinical follow-up was 100%. Eighty-six of 87 patients
were alive, and all were free of MR signs and symptoms.
No patient required reoperation for recurrent MR. Echocar-
diographic follow-up has been obtained at the discretion of
the referring cardiologists. In many cases, in the absence of
clinical symptoms or examination suggesting MR, referring
cardiologists have opted to defer surveillance echocardio-
grams. Echocardiograms have been obtained on 58 patients
with a mean follow-up of 1 year. This revealed a mean MR
grade of 0.4, and no patients had significant (>2þ) MR. Re-
sults were equivalent between minimally invasive and
sternotomy cases. Several patients had echocardiography
follow-up 3 years after surgery and continued to have noMR.
DISCUSSION
The McGoon repair was probably first overshadowed by
the introduction of prosthetic mitral valve replacement and
then later supplanted by Carpentier’s techniques. Neverthe-
less, long-term follow-up of 116 patients who underwent
leaflet plication at the Mayo Clinic from 1958 to 1980
revealed good durability with only 20 patients requiring
reoperation for recurrent MR, 10 because of annuloplasty
failure.11 The widespread adoption of the classic Carpentier
quadrangular resection supports its elegance, reproducibil-
ity, and durability. Long-term freedom from reoperation for
recurrent MR has been reported as high as 98% at 14
years.12 Despite the overwhelming success, some draw-
backs exist: (1) Resection is irrevocable; inability to recon-
struct mandates valve replacement. (2) Resecting a wide
prolapsed segment yields a diminutive minimally func-
tional posterior leaflet or monoleaflet repair. (3) Annular
plication to facilitate leaflet reapproximation can exces-
sively elevate the height of the posterior leaflet, risking
SAM, and overly reduce posterior annular arc length, re-
ducing mitral orifice area. (4) Leaflet sliding requires pre-
cise, time-consuming leaflet detachment and reattachment
that can also reduce leaflet surface area and functionality.
Time prolongation is magnified in minimally invasive oper-
ations. (5) Annuloplasty rings implanted in these settings
tend to approximate the anterior leaflet size. In some pa-
tients, this smaller valve may risk dynamic mitral stenosis,
as learned from ischemic MR repair.13 (6) The potential
for resecting insufficient tissue, particularly in Barlow’s
pathology, and reducing the septal–lateral dimension
with ring annuloplasty may adversely alter the heightrdiovascular Surgery c Volume 143, Number 3 751
Surgical Techniquesrelationship between the anterior and posterior leaflets,
risking SAM.
Surgeons continue to evolve this classic repair. In seeking
to preserve leaflet area, a triangular resection reduces the
amount of leaflet cutting and suturing and precludes the
need for annular plication or leaflet sliding.14 To ensure
proper posterior leaflet height reduction after triangular
resection, an innovative technique of folding part of the re-
sidual leaflet during reapproximation has also been de-
scribed.15 Horizontally folding prolapsed leaflet tissue
under itself without resection has also been reported.16 Pro-
lapse can alternately be corrected with polytetrafluoroethy-
lene (Gore-Tex) neochords, which may be premeasured
using TEE.17 Overly redundant leaflet tissue can be ad-
dressed with a combined leaflet height-reducing and neo-
chord procedure, such as the creative ‘‘haircut repair.’’18
The biomechanical advantage of preserving leaflet tissue
has also been studied in a laboratory setting. Sophisticated
ex vivo left heart simulator analysis of explanted, manipu-
lated mitral valves has shown enhanced coaptation length
and leaflet mobility with a nonresectional repair technique
compared with quadrangular resection.19
Potential drawbacks with these modifications still exist.
A triangular resection still entails leaflet cutting and
reapproximation. An aggressive folding plasty can overly
reduce the posterior leaflet surface area, yielding a mono-
leaflet repair. Precise neochord sizing can be difficult. A
neochord tied in a cardioplegia-arrested ventricle may be
foreshortened. On ventricular filling, the leaflet will be teth-
ered, yielding residual MR. A neochord tied overly long
will yield persistent leaflet prolapse and MR.
The interest in preserving leaflet tissue, coupled with the
drive for efficient, minimally invasive techniques may rein-
vigorate the appeal of leaflet plication. Inverting a small
amount of leaflet into the ventricle eliminates excessive re-
dundant tissue while preserving functionally useful mobile
leaflet tissue for coaptation surface. Slightly reducing the
size of the posterior leaflet by this manner effectively bal-
ances the height relationship of the anterior and posterior
leaflets and avoids an excessively high posterior leaflet
that may predispose one to SAM. Finally, this approach
avoids posterior annulus arc length reduction, preserving
a maximal mitral valve total orifice area. In some respects,
this technique resembles a small triangular resection with-
out the need for resection.
This repair is also easily fine-tuned with additional passes
of the suture. We frequently use the first half of the double-
running suture line to invert a minimal amount of leaflet tis-
sue, gently pressure test with saline to examine leaflet
geometry, and then use the second half of the suture to re-
inforce the first line or, if needed, invert additional tissue
by placing slightly wider bites. Polytetrafluoroethylene
(Gore-Tex) suture does not damage leaflet tissue and can
be easily removed and repositioned if desired. This752 The Journal of Thoracic and Cardiovascular Surgreversibility offers a significant advantage over resection
techniques and does not preclude using other repair tech-
niques. The rapid and efficient single suture technique par-
ticularly facilitates minimally invasive operations.
Although P2 segment repairs were most common, P1 and
P3 segment and anterior leaflet disease were also addressed
with this technique.
Limitations of this repair include potentially inverting too
much tissue and restricting the leaflet. This can be corrected
by removing theGore-Tex suture and resuturingwith less tis-
sue. Also, excess bulky tissue may produce anterior protru-
sion of the repaired leaflet, risking SAM. Calcified leaflets
may be difficult to bend and invert. Limitations of the study
are its retrospective nature and duration of follow-up. All pa-
tients are undergoing continued long-term follow-up.CONCLUSIONS
This study reports a series of 87 patients who underwent
nonresectional leaflet remodeling mitral valve repair. Pro-
lapsed leaflet tissue was inverted into the left ventricle
yielding a functional leaflet and eliminating MR. Good
perioperative outcomes were observed.References
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catheter through a subclavian accessBertrand Marcheix, MD, PhD,a Etienne Grunenwald, MD,a Didier Carrie, MD, PhD,b and
Nicolas Dumonteil, MD,b Toulouse, FranceTranscatheter aortic bioprosthesis implantation is a new op-
tion for patients at high surgical risk with severe symptom-
atic aortic valve stenosis.1 The main alternatives to
transfemoral access are currently the transapical approach
with an Edwards Sapien prosthesis (Edwards Lifesciences,
Inc, Irvine, Calif) and the subclavian approach with the
Medtronic CoreValve prosthesis (Medtronic, Inc, Minneap-
olis, Minn),2 with some observational and noncontrolled
data indicating that the latter could be less invasive.3 The
subclavian approach was not developed with the new gener-
ation Sapien XT bioprosthesis delivered by its NovaFlex
catheter (Edwards Lifesciences) because of theoretic tech-
nical issues, including difficulties in aligning the prosthesis
over the balloon in the patient, outside the delivery sheath in
the ascending aorta.
We report the implantation of a Sapien XT bioprosthe-
sis with the NovaFlex catheter through a left subclavian
approach.
CLINICAL SUMMARY
An 82-year-old woman was referred for symptomatic se-
vere aortic stenosis with New York Heart Association func-
tional dyspnea class III, indexed effective orifice area of0.45 cm2/m2, mean gradient of 38 mmHg, maximal gradient
of 61 mm Hg, peak aortic jet velocity of 3.7 m/s, stroke vol-
ume of 70 mL, and left ventricular ejection fraction of 25%.
The patient had a history of diabetes mellitus, obesity
(body mass index 36.7 kg/m2), chronic obstructive and re-
strictive pulmonary disease (forced expiratory volume in
1 second of 800 mL [55%], forced vital capacity of 1.4 L
[56%]), peripheral artery disease, and coronary artery
disease with history of previous percutaneous coronary in-
tervention on the left anterior descending artery with no re-
maining significant stenosis. Low-dose (15 mg) dobutamine
echocardiography detected contractile reserve (effective or-
ifice area of 0.49 cm2/m2. mean gradient of 49mmHg, max-
imal gradient of 75 mm Hg, peak aortic jet velocity of
4.3 m/s, stroke volume of 87 mL, and left ventricular ejec-
tion fraction of 37%).
A transcatheter aortic valve implantation was proposed,
because this patient was considered a high-risk surgical
candidate for whom conventional surgery was contraindi-
cated (logistic EuroSCORE of 46.48%, Society of Thoracic
Surgeons Score of 13.4%).
The aortic annulus, as measured by transesophageal
echocardiography, was 24 mm. The iliofemoral arteries
were not suitable for transarterial access (Figure 1, A). A
transapical approach was contraindicated because of severe
respiratory dysfunction. The computed tomographic scan
showed a left subclavian artery without stenosis with a di-
ameter of 8 mm (Figure 1, B and C) and a distance of
13.6 mm between the aortic annulus and the ostium of the
left subclavian artery (Figure 1, D and E).
The procedure was performed with the patient under gen-
eral anesthesia through surgical cutdown and isolation of
the left axillary artery. After heparinization (50 UI/kg, acti-
vated clotting time of 200–250 seconds), the 19F sheath was
directly inserted in the axillary artery toward the aortic arch
over an Amplatz extra stiff wire (Cook Medical Inc,rdiovascular Surgery c Volume 143, Number 3 753
